$2.70
▼ -0.4% Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference
Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis
Overview
52-week range
$1.35
$3.58
61% of range
Avg surprise (last 2)
+42.5%
Avg reaction (last 2)
+2.2%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.22 | — | — | -57.1% | -2.3% | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.09 | $-0.20 | +55.0% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.14 | $-0.20 | +30.0% | — | +6.6% | earnings |
| Fri Mar 31, 2023 | Mar 2023 | $0.04 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $0.04 | — | — | — | — | financials |
| Thu Mar 31, 2022 | Mar 2022 | $0.02 | — | — | — | — | financials |
| Thu Sep 30, 2021 | Sep 2021 | $0.01 | — | — | — | — | financials |
| Wed Jun 30, 2021 | Jun 2021 | $0.01 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | — | — | $-8M | — | — | — | $-3M | $-3M |
| EPS (diluted) | $0.04 | — | $0.04 | — | $0.02 | — | $0.01 | $0.01 |
Balance sheet (quarterly)
| Metric | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $21M | $14M | $11M | $10M | $14M | $15M | $38M | $45M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $34M | $42M | $49M | $55M | $59M | $63M | $66M | $69M |
| Total assets | $35M | $43M | $50M | $56M | $61M | $64M | $67M | $71M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $7M | $7M | $6M | $5M | $4M | $3M | $2M | $2M |
| Total equity | — | $36M | $45M | — | — | $61M | $66M | $68M |
Implied volatility — last 90 days
No IV snapshots yet for CMMB.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.